Tumor-Associated Macrophages: Recent Insights and Therapies

被引:458
作者
Zhou, Jiawei [1 ,2 ,3 ,4 ]
Tang, Ziwei [1 ,2 ,3 ,4 ]
Gao, Siyang [4 ]
Li, Chunyu [4 ]
Feng, Yiting [4 ]
Zhou, Xikun [1 ,2 ,3 ]
机构
[1] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu, Peoples R China
[3] Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China
[4] Sichuan Univ, State Key Lab Oral Dis, Natl Clin Res Ctr Oral Dis, West China Coll Stomatol,Chinese Acad Med Sci,Res, Chengdu, Peoples R China
关键词
macrophages; tumors; tumor-associated macrophages; immunity; immunity therapy; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER CELLS; EXPRESSION; ACTIVATION; BLOCKADE; PD-1; PHAGOCYTOSIS; METASTASIS; INHIBITION; IL-10;
D O I
10.3389/fonc.2020.00188
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Macrophages, which have functions of engulfing and digesting foreign substances, can clear away harmful matter, including cellular debris and tumor cells. Based on the condition of the internal environment, circulating monocytes give rise to mature macrophages, and when they are recruited into the tumor microenvironment and in suitable conditions, they are converted into tumor-associated macrophages (TAMs). Generally, macrophages grow into two main groups called classically activated macrophages (M1) and alternatively activated macrophages (M2). M2 and a small fraction of M1 cells, also known as TAMs, not only lack the function of phagocytizing tumor cells but also help these tumor cells escape from being killed and help them spread to other tissues and organs. In this review, we introduce several mechanisms by which macrophages play a role in the immune regulation of tumor cells, including both killing factors and promoting effects. Furthermore, the targeted therapy for treating tumors based on macrophages is also referred to in our review. We confirm that further studies of macrophage-focused therapeutic strategies and their use in clinical practice are needed to verify their superior efficacy and potential in cancer treatment.
引用
收藏
页数:13
相关论文
共 86 条
[31]   Replication Study: The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors [J].
Horrigan, Stephen K. .
ELIFE, 2017, 6
[32]   IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1 [J].
Jenkins, Stephen J. ;
Ruckerl, Dominik ;
Thomas, Graham D. ;
Hewitson, James P. ;
Duncan, Sheelagh ;
Brombacher, Frank ;
Maizels, Rick M. ;
Hume, David A. ;
Allen, Judith E. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2013, 210 (11) :2477-2491
[33]   On the horizon: Flexible immune recognition outside lymphocytes [J].
Kaminski, Wolfgang E. ;
Beham, Alexander W. ;
Kzhyshkowska, Julia ;
Gratchev, Alexei ;
Puellmann, Kerstin .
IMMUNOBIOLOGY, 2013, 218 (03) :418-426
[34]   Expression of programmed death 1 (PD-1) and its ligand (PD-L1) in thymic epithelial tumors: Impact on treatment efficacy and alteration in expression after chemotherapy [J].
Katsuya, Yuki ;
Horinouchi, Hidehito ;
Asao, Tetsuhiko ;
Kitahara, Shinsuke ;
Goto, Yasushi ;
Kanda, Shintaro ;
Fujiwara, Yutaka ;
Nokihara, Hiroshi ;
Yamamoto, Noboru ;
Watanabe, Shun-ichi ;
Tsuta, Koji ;
Ohe, Yuichiro .
LUNG CANCER, 2016, 99 :4-10
[35]   Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways [J].
Leu, CM ;
Wong, FH ;
Chang, CM ;
Huang, SF ;
Hu, CP .
ONCOGENE, 2003, 22 (49) :7809-7818
[36]   M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway [J].
Liu, Chao-Ying ;
Xu, Juan-Ying ;
Shi, Xiao-Yan ;
Huang, Wei ;
Ruan, Ting-Yan ;
Xie, Ping ;
Ding, Jun-Li .
LABORATORY INVESTIGATION, 2013, 93 (07) :844-854
[37]   Glutaminyl cyclase is an enzymatic modifier of the CD47-SIRPα axis and a target for cancer immunotherapy [J].
Logtenberg, Meike E. W. ;
Jansen, J. H. Marco ;
Raaben, Matthijs ;
Toebes, Mireille ;
Franke, Katka ;
Brandsma, Arianne M. ;
Matlung, Hanke L. ;
Fauster, Astrid ;
Gomez-Eerland, Raquel ;
Bakker, Noor A. M. ;
van der Schot, Simone ;
Marijt, Koen A. ;
Verdoes, Martijn ;
Haanen, John B. A. G. ;
van den Berg, Joost H. ;
Neefjes, Jacques ;
van den Berg, Timo K. ;
Brummelkamp, Thijn R. ;
Leusen, Jeanette H. W. ;
Scheeren, Ferenc A. ;
Schumacher, Ton N. .
NATURE MEDICINE, 2019, 25 (04) :612-+
[38]   The chemokine system in cancer biology and therapy [J].
Mantovani, Alberto ;
Savino, Benedetta ;
Locati, Massimo ;
Zammataro, Luca ;
Allavena, Paola ;
Bonecchi, Raffaella .
CYTOKINE & GROWTH FACTOR REVIEWS, 2010, 21 (01) :27-39
[39]   CD169+ macrophages at the crossroads of antigen presentation [J].
Martinez-Pomares, Luisa ;
Gordon, Siamon .
TRENDS IN IMMUNOLOGY, 2012, 33 (02) :66-70
[40]   Fe chimeric protein containing the cysteine-rich domain of the murine mannose receptor binds to macrophages from splenic marginal zone and lymph node subcapsular sinus and to germinal centers [J].
MartinezPomares, L ;
KoscoVilbois, M ;
Darley, E ;
Tree, P ;
Herren, S ;
Bonnefoy, JY ;
Gordon, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (05) :1927-1937